Times Square Capital Management, LLC Biolife Solutions Inc Transaction History

Times Square Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$14.64 - $26.7 $882,499 - $1.61 Million	60,280 Added 12.38%	547,350 $12.5 Million
Q2 2022 Aug 05, 2022	BUY	$10.54 - $24.2 $55,861 - $128,260	5,300 Added 1.1%	487,070 $6.73 Million
Q1 2022 May 06, 2022	BUY	$20.81 - $37.29 $52,025 - $93,225	2,500 Added 0.52%	481,770 $11 Million
Q4 2021 Feb 04, 2022	BUY	$32.99 - $58.55 $2.4 Million - $4.26 Million	72,800 Added 17.91%	479,270 $17.9 Million
Q3 2021 Nov 08, 2021	SELL	$42.03 - $60.5 $2.62 Million - $3.77 Million	-62,330 Reduced 13.3%	406,470 $17.2 Million
Q2 2021 Aug 09, 2021	SELL	$29.51 - $44.62 $560,690 - $847,780	-19,000 Reduced 3.9%	468,800 $20.9 Million
Q1 2021 May 12, 2021	SELL	$32.95 - $44.24 $932,485 - $1.25 Million	-28,300 Reduced 5.48%	487,800 $17.6 Million
Q4 2020 Feb 12, 2021	SELL	$27.5 - $45.75 $222,750 - $370,575	-8,100 Reduced 1.55%	516,100 $20.6 Million
Q3 2020 Nov 06, 2020	BUY	$16.04 - $28.94 $8.41 Million - $15.2 Million	524,200 New	524,200 $15.2 Million

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.